[1] OCHANI R, ASAD A, YASMIN F, et al.COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management[J]. Infez Med, 2021, 29(1): 20-36. [2] Chinese Society of General Practice, China Association of Traditional Chinese Medicine Branch of General Practice, Respiratory Disease Prevention and Control Speciality Society of Chinese Preventive Medicine Association, et al. Guideline for diagnosis, treatment and management of COVID-19 in primary care (first edition)[J]. Chinese Journal of General Practitioners(中华全科医师杂志), 2023, 22(2): 115-137. [3] KIM DH, KIM JH, OH IS, et al.Adverse events following COVID-19 vaccination in adolescents: insights from pharmacovigilance study of vigiBase[J]. J Korean Med Sci, 2024, 39(8): e76. [4] LI M, WANG H, TIAN L, et al.COVID-19 vaccine development: milestones, lessons and prospects[J]. Signal Transduct Target Ther, 2022, 7(1): 146. [5] Branch of Organ Transplantation of Chinese Medical Association. Expert consensus on SARS-CoV-2 vaccination and prevention in kidney transplant recipients in China[J]. Chinese Journal of Organ Transplantation(中华器官移植杂志), 2023, 44(1): 6-16. [6] CHEUNG KS, MOK CH, MAO X, et al.COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis[J]. Clin Mol Hepatol, 2022, 28(4): 890-911. [7] ZHANG W, HAN F, WU X, et al.COVID-19 in the immunocompromised population: data from renal allograft recipients throughout full cycle of the outbreak in Hubei province, China[J]. Chin Med J (Engl), 2021, 135(2): 228-230. [8] TU ZH, JIN PB, CHEN DY, et al.Evaluating the response and safety of inactivated COVID-19 vaccines in liver transplant Recipients[J]. Infect Drug Resist, 2022, 15: 2469-2474. [9] LEE A, WONG SY, CHAI L, et al.Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis[J]. BMJ, 2022, 376: e068632. [10] National Medical Center for Infectious Diseases, Branch of Organ Transplantation of Chinese Medical Association, Organ Transplant Rehabilitation Committee of China Association Rehabilitation Medicine, et al. Expert consensus on diagnosis and treatment of SARS-CoV-2 infection in solid organ transplant recipients (2023 edition)[J]. Chinese Journal of Organ Transplantation(中华器官移植杂志), 2023, 14(2): 163-182. [11] SHIMABUKURO TT, NGUYEN M, MARTIN D, et al.Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)[J]. Vaccine, 2015, 33(36): 4398-4405. [12] YANG QY, SU J, ZHANG X, et al.Analysis of adverse events of three types of COVID-19 vaccines marketed in the United States based on VAERS database[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(10): 1141-1147. [13] BOUSQUET C, LAGIER G, LILLO-LE LA, et al.Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions[J]. Drug Saf, 2005, 28(1): 19-34. [14] ZHANG B, GUO DH, GUO HL, et al.Analysis of COVID-19 vaccine-related adverse event reports based on the American Vaccine Adverse Event Reporting System[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2021, 18(2): 114-117. [15] LIM J, PAEK JH, SHIN HC, et al.Acute interstitial nephritis with acute kidney injury after COVID-19 vaccination: a case report[J]. Clin Exp Vaccine Res, 2024, 13(1): 68-71. [16] RYAD R, OSMAN A, ALMUSA A, et al.Dermatomyositis flare-up following the SARS-CoV-2 vaccine: a case report and literature review[J]. Cureus, 2023, 15(8): e44324. [17] RUGGIERO R, DONNIACUO M, MASCOLO A, et al.COVID-19 vaccines and atrial fibrillation: analysis of the post-marketing pharmacovigilance european database[J]. Biomedicines, 2023, 11(6): 1584. [18] SHROFF H.COVID-19 vaccine-induced liver injury[J]. Curr Opin Gastroenterol, 2024, 40(3): 119-125. [19] BOYARSKY BJ, OU MT, GREENBERG RS, et al.Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients[J]. Transplantation, 2021, 105(5): e56-e57. [20] EFROS O, ANTEBY R, HALFON M, et al.Efficacy and safety of third dose of the COVID-19 vaccine among solid organ transplant recipients: A systemic review and Meta-analysis[J]. Vaccines (Basel), 2022, 10(1): 95. [21] Chinese Society of Hepatology, Chinese Medical Association. Rapid guideline for COVID-19 vaccination in patients with chronic liver diseases, hepatolbiliary malignancy and liver transplant[J]. Chinese Journal of Hepatology(中华肝脏病杂志), 2021, 29(6): 523-526. [22] BHOORI S, ROSSI RE, CITTERIO D, et al.COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy[J]. Lancet Gastroenterol Hepatol, 2020, 5(6): 532-533. [23] GUPTA N, KAUR H, YADAV PD, et al.Clinical characterization and genomic analysis of samples from COVID-19 breakthrough infections during the second wave among the various states of india[J]. Viruses, 2021, 13(9): 1782. [24] Branch of Organ Transplantation of Chinese Medical Association. Expert consensus on SARS-CoV-2 vaccination and prevention in kidney transplant recipients in China[J]. Chinese Journal of Organ Transplantation(中华器官移植杂志), 2023, 44(1): 6-16. [25] BOYARSKY BJ, CHIANG TP, OU MT, et al.Antibody response to the janssen COVID-19 vaccine in solid organ transplant recipients[J]. Transplantation, 2021, 105(8): e82-e83. [26] SHIMABUKURO TT, NGUYEN M, MARTIN D, et al.Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)[J]. Vaccine, 2015, 33(36): 4398-4405. [27] VARRICCHIO F, ISKANDER J, DESTEFANO F, et al.Understanding vaccine safety information from the Vaccine Adverse Event Reporting System[J]. Pediatr Infect Dis J, 2004, 23(4): 287-294. |